Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis

Abstract Background Long COVID or Post-acute sequelae of COVID-19 is an emerging syndrome, recognized in COVID-19 patients who suffer from mild to severe illness and do not recover completely. Most studies define Long COVID, through symptoms like fatigue, brain fog, joint pain, and headache prevaili...

Full description

Saved in:
Bibliographic Details
Main Authors: Najeeha Talat Iqbal, Hana Khan, Aqsa Khalid, Syed Faisal Mahmood, Nosheen Nasir, Iffat Khanum, Isadora de Siqueira, Wes Van Voorhis
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-024-00986-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585652161478656
author Najeeha Talat Iqbal
Hana Khan
Aqsa Khalid
Syed Faisal Mahmood
Nosheen Nasir
Iffat Khanum
Isadora de Siqueira
Wes Van Voorhis
author_facet Najeeha Talat Iqbal
Hana Khan
Aqsa Khalid
Syed Faisal Mahmood
Nosheen Nasir
Iffat Khanum
Isadora de Siqueira
Wes Van Voorhis
author_sort Najeeha Talat Iqbal
collection DOAJ
description Abstract Background Long COVID or Post-acute sequelae of COVID-19 is an emerging syndrome, recognized in COVID-19 patients who suffer from mild to severe illness and do not recover completely. Most studies define Long COVID, through symptoms like fatigue, brain fog, joint pain, and headache prevailing four or more weeks post-initial infection. Global variations in Long COVID presentation and symptoms make it challenging to standardize features of Long COVID. Long COVID appears to be accompanied by an auto-immune multi-faceted syndrome where the virus or viral antigen persistence causes continuous stimulation of the immune response, resulting in multi-organ immune dysregulation. Main text This review is focused on understanding the risk factors of Long COVID with a special emphasis on the dysregulation of the gut-brain axis. Two proposed mechanisms are discussed here. The first mechanism is related to the dysfunction of angiotensin-converting enzyme 2 receptor due to Severe Acute Respiratory Syndrome Corona Virus 2 infection, leading to impaired mTOR pathway activation, reduced AMP secretion, and causing dysbiotic changes in the gut. Secondly, gut-brain axis dysregulation accompanied by decreased production of short-chain fatty acids, impaired enteroendocrine cell function, and increased leakiness of the gut, which favors translocation of pathogens or lipopolysaccharide in circulation causing the release of pro-inflammatory cytokines. The altered Hypothalamic-Pituitary-Adrenal axis is accompanied by the reduced level of neurotransmitter, and decreased stimulation of the vagus nerve, which may cause neuroinflammation and dysregulation of serum cortisol levels. The dysbiotic microbiome in Long COVID patients is characterized by a decrease in beneficial short chain fatty acid-producing bacteria (Faecalibacterium, Ruminococcus, Dorea, and Bifidobacterium) and an increase in opportunistic bacteria (Corynebacterium, Streptococcus, Enterococcus). This dysbiosis is transient and may be impacted by interventions including probiotics, and dietary supplements. Conclusions Further studies are required to understand the geographic variation, racial and ethnic differences in phenotypes of Long COVID, the influence of viral strains on existing and emerging phenotypes, to explore long-term effects of gut dysbiosis, and gut-brain axis dysregulation, as well as the potential role of diet and probiotics in alleviating those symptoms.
format Article
id doaj-art-96da6d9f6df94c80b277f627bf35e57c
institution Kabale University
issn 1528-3658
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj-art-96da6d9f6df94c80b277f627bf35e57c2025-01-26T12:38:39ZengBMCMolecular Medicine1528-36582025-01-0131111910.1186/s10020-024-00986-6Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosisNajeeha Talat Iqbal0Hana Khan1Aqsa Khalid2Syed Faisal Mahmood3Nosheen Nasir4Iffat Khanum5Isadora de Siqueira6Wes Van Voorhis7Department of Biological and Biomedical Sciences, Department of Pediatrics and Child Health, Aga Khan UniversityUndergraduate Medical Education (UGME), Year II, Aga Khan UniversityDepartment of Pediatrics & Child Health, Aga Khan UniversityDepartment of Medicine, Aga Khan UniversityDepartment of Medicine, Aga Khan UniversityDepartment of Medicine, Aga Khan UniversityFiocruz Salvador, Instituto Gonçalo MonizCenter for Emerging and Re-emerging Infectious Diseases (CERID), University of WashingtonAbstract Background Long COVID or Post-acute sequelae of COVID-19 is an emerging syndrome, recognized in COVID-19 patients who suffer from mild to severe illness and do not recover completely. Most studies define Long COVID, through symptoms like fatigue, brain fog, joint pain, and headache prevailing four or more weeks post-initial infection. Global variations in Long COVID presentation and symptoms make it challenging to standardize features of Long COVID. Long COVID appears to be accompanied by an auto-immune multi-faceted syndrome where the virus or viral antigen persistence causes continuous stimulation of the immune response, resulting in multi-organ immune dysregulation. Main text This review is focused on understanding the risk factors of Long COVID with a special emphasis on the dysregulation of the gut-brain axis. Two proposed mechanisms are discussed here. The first mechanism is related to the dysfunction of angiotensin-converting enzyme 2 receptor due to Severe Acute Respiratory Syndrome Corona Virus 2 infection, leading to impaired mTOR pathway activation, reduced AMP secretion, and causing dysbiotic changes in the gut. Secondly, gut-brain axis dysregulation accompanied by decreased production of short-chain fatty acids, impaired enteroendocrine cell function, and increased leakiness of the gut, which favors translocation of pathogens or lipopolysaccharide in circulation causing the release of pro-inflammatory cytokines. The altered Hypothalamic-Pituitary-Adrenal axis is accompanied by the reduced level of neurotransmitter, and decreased stimulation of the vagus nerve, which may cause neuroinflammation and dysregulation of serum cortisol levels. The dysbiotic microbiome in Long COVID patients is characterized by a decrease in beneficial short chain fatty acid-producing bacteria (Faecalibacterium, Ruminococcus, Dorea, and Bifidobacterium) and an increase in opportunistic bacteria (Corynebacterium, Streptococcus, Enterococcus). This dysbiosis is transient and may be impacted by interventions including probiotics, and dietary supplements. Conclusions Further studies are required to understand the geographic variation, racial and ethnic differences in phenotypes of Long COVID, the influence of viral strains on existing and emerging phenotypes, to explore long-term effects of gut dysbiosis, and gut-brain axis dysregulation, as well as the potential role of diet and probiotics in alleviating those symptoms.https://doi.org/10.1186/s10020-024-00986-6MicrobiotaCOVID-19Gut-brain axisInflammationLong COVIDPASC
spellingShingle Najeeha Talat Iqbal
Hana Khan
Aqsa Khalid
Syed Faisal Mahmood
Nosheen Nasir
Iffat Khanum
Isadora de Siqueira
Wes Van Voorhis
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
Molecular Medicine
Microbiota
COVID-19
Gut-brain axis
Inflammation
Long COVID
PASC
title Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
title_full Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
title_fullStr Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
title_full_unstemmed Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
title_short Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
title_sort chronic inflammation in post acute sequelae of covid 19 modulates gut microbiome a review of literature on covid 19 sequelae and gut dysbiosis
topic Microbiota
COVID-19
Gut-brain axis
Inflammation
Long COVID
PASC
url https://doi.org/10.1186/s10020-024-00986-6
work_keys_str_mv AT najeehatalatiqbal chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT hanakhan chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT aqsakhalid chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT syedfaisalmahmood chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT nosheennasir chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT iffatkhanum chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT isadoradesiqueira chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis
AT wesvanvoorhis chronicinflammationinpostacutesequelaeofcovid19modulatesgutmicrobiomeareviewofliteratureoncovid19sequelaeandgutdysbiosis